沛肽（上海）医药科技

Peptide (Shanghai) Pharmaceutical Technology is a biopharmaceutical company focused on the research and development of next-generation peptide drugs. Based in Shanghai's Zhangjiang High-Tech Park, the company utilizes advanced peptide engineering technologies to develop long-acting therapies for metabolic and endocrine disorders. Their primary research focus includes multi-receptor agonists targeting GLP-1, GIP, and Glucagon for the treatment of obesity and type 2 diabetes. The company aims to improve patient compliance and therapeutic efficacy through optimized molecular design and extended half-lives. Peptide (Shanghai) is part of the growing ecosystem of innovative Chinese biotechs addressing global metabolic health challenges.